Chemotherapy in geriatric patients with early stage HER2+breast cancer: A National Cancer Database analysis

被引：0
|
作者：
Sandoval-Leon, Ana
Chamorro, Yolcar
Rubens, Muni
Roy, Mukesh
Carcas, Lauren
Dempsey, Naomi
Ahluwalia, Manmeet
Mahtani, Reshma
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PS13-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS13-08
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Are we overtreating patients with T1a HER2+breast cancer?: An analysis of chemotherapy use from the National Cancer Database
    Williams, Austin
    Sterbling, Helene
    Kassar, Odette
    Murray, Allison
    Sogunro, Olutayo
    De la Cruz, Lucy
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 241 - 242
  • [2] Are We Overtreating Patients With T1a HER2+Breast Cancer? An Analysis of the National Cancer Database
    Williams, Austin D.
    Solis, Odette
    Sterbling, Helene M.
    Murray, Allison
    Sogunro, Olutayo
    De la Cruz, Lucy M.
    CLINICAL BREAST CANCER, 2022, 22 (08) : 828 - 839
  • [3] Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+breast cancer: a National Cancer Database analysis
    Cao, Lifen
    Shenk, Robert
    Stabellini, Nickolas
    Miller, Megan E.
    Towe, Christopher W.
    Montero, Alberto J.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (01) : 169 - 176
  • [4] Survival of patients with advanced HER2+breast cancer. Analysis of a cancer center database
    Sanchez, Cesar
    Dominguez, Francisco
    Galindo, Hector
    Camus, Mauricio
    Oddo, David
    Villarroel, Alejandra
    Razmilic, Dravna
    Elena Navarro, Maria
    Perez-Sepulveda, Alejandra
    Medina, Lidia
    Lopez, Valeska
    Aceved, Francisco
    REVISTA MEDICA DE CHILE, 2018, 146 (10) : 1095 - 1101
  • [5] Investigating the immune profile of early stage HER2+breast cancer patients receiving chemotherapy and HER2-targeted therapies
    Collins, Denis M.
    Gaynor, Nicola
    Madden, Stephen
    Toomey, Sinead
    Qiu, Ji
    Blayney, Jaine
    Blanco, Alfonso
    Fletcher, Jean
    Moran, Barry
    Kaukonen, Damien
    Ramirez, Javier Sanchez
    Kay, Elaine
    O'Connor, Darran
    Teiserskiene, Ausra
    Eustace, Alex
    Kennedy, Richard
    LaBaer, Joshua
    Gallagher, William
    Hennessy, Bryan
    Crown, John
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 487 - 487
  • [6] Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
    Huiyue Li
    Jennifer K. Plichta
    Kan Li
    Yizi Jin
    Samantha M. Thomas
    Fei Ma
    Li Tang
    Qingyi Wei
    You-Wen He
    Qichen Chen
    Yuanyuan Guo
    Yueping Liu
    Jian Zhang
    Sheng Luo
    Breast Cancer Research and Treatment, 2024, 204 : 89 - 105
  • [7] Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
    Li, Huiyue
    Plichta, Jennifer K.
    Li, Kan
    Jin, Yizi
    Thomas, Samantha M.
    Ma, Fei
    Tang, Li
    Wei, Qingyi
    He, You-Wen
    Chen, Qichen
    Guo, Yuanyuan
    Liu, Yueping
    Zhang, Jian
    Luo, Sheng
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 204 (01) : 89 - 105
  • [8] Adjuvant trastuzumab and vinorelbine for early-stage HER2+breast cancer
    McLaughlin, Shannon
    Nakajima, Erika
    Bar, Yael
    Hutchinson, Jennifer A. A.
    Shin, Jennifer
    Moy, Beverly
    Isakoff, Steven J. J.
    Bardia, Aditya
    Kuter, Irene
    Spring, Laura M. M.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [9] HER2+breast cancer
    Hicks, David G.
    Kulkarni, Swati
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (02) : 263 - 273
  • [10] Commission on Cancer CP3R Compliance Rates for Treatment of Patients With Triple Negative and HER2+Breast Cancer: A National Cancer Database Analysis
    Mohan, Srivarshini C.
    Tseng, Joshua
    Srour, Marissa
    Chung, Alice
    Marumoto, Ashley
    Angarita, Stephanie
    Giuliano, Armando E.
    Amersi, Farin
    AMERICAN SURGEON, 2021, 87 (10) : 1539 - 1544
12345